Spikevax XFG (50 Microgramm) Injektionsdispersion in einer Fertigspritze
Spikevax XFG (50 Microgramm) Injektionsdispersion in einer Fertigspritze is a medicine authorised by Swissmedic under authorisation number 70847. The authorisation holder is Moderna Switzerland GmbH. The medicinal product code is Vaccines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 10 August 2026 and the authorisation is limited until 09 August 2031. ATC code J07BN01 places the medicine in the group Vaccines.
| Authorisation number | 70847 |
|---|---|
| Name | Spikevax XFG (50 Microgramm) Injektionsdispersion in einer Fertigspritze |
| Full name | Spikevax XFG (50 Microgramm) Injektionsdispersion in einer Fertigspritze |
| Authorisation holder | Moderna Switzerland GmbH |
| Medicinal product code | Vaccines |
| Dispensing category | B · Prescription only |
| ATC code | J07BN01 |
| First authorisation | 10 August 2026 |
| Authorisation validity | 09 August 2031 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Spikevax XFG (50 Microgramm) Injektionsdispersion in einer Fertigspritze | B | 10 August 2026 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Fertigspritze(n) | J07BN01 | 08.08. | B |
| 2 | 10 | Fertigspritze(n) | J07BN01 | 08.08. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Spikevax XFG (50 Microgramm) Injektionsdispersion in einer Fertigspritze authorised in Switzerland?
Yes. Spikevax XFG (50 Microgramm) Injektionsdispersion in einer Fertigspritze is authorised by Swissmedic under authorisation number 70847, data as of 01 September 2026. The authorisation is limited until 09 August 2031.
Which dispensing category does Spikevax XFG (50 Microgramm) Injektionsdispersion in einer Fertigspritze have?
Spikevax XFG (50 Microgramm) Injektionsdispersion in einer Fertigspritze is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Spikevax XFG (50 Microgramm) Injektionsdispersion in einer Fertigspritze?
The authorisation holder is Moderna Switzerland GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.